| 000 | 01593 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250511225057.0 | ||
| 264 | 0 | _c19901221 | |
| 008 | 199012s 0 0 eng d | ||
| 022 | _a0954-6111 | ||
| 024 | 7 |
_a10.1016/s0954-6111(08)80060-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBoulet, L P | |
| 245 | 0 | 0 |
_aTolerance to reduction of oral steroid dosage in severely asthmatic patients receiving nedocromil sodium. _h[electronic resource] |
| 260 |
_bRespiratory medicine _cJul 1990 |
||
| 300 |
_a317-23 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadverse effects |
| 650 | 0 | 4 |
_aAsthma _xdrug therapy |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNedocromil |
| 650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
| 650 | 0 | 4 |
_aQuinolones _xadverse effects |
| 700 | 1 | _aCartier, A | |
| 700 | 1 | _aCockcroft, D W | |
| 700 | 1 | _aGruber, J M | |
| 700 | 1 | _aLaberge, F | |
| 700 | 1 | _aMacDonald, G F | |
| 700 | 1 | _aMalo, J L | |
| 700 | 1 | _aMazza, J A | |
| 700 | 1 | _aMoote, W D | |
| 700 | 1 | _aSandham, J D | |
| 773 | 0 |
_tRespiratory medicine _gvol. 84 _gno. 4 _gp. 317-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0954-6111(08)80060-1 _zAvailable from publisher's website |
| 999 |
_c2179177 _d2179177 |
||